Skip to main content
logo
Knight Therapeutics Inc. (TSX:GUD)
Canada flag Canada · Delayed Price · Currency is CAD
6.14
-0.01 (-0.16%)
Nov 14, 2025, 4:00 PM EST

Plumas Bancorp Revenue

Knight Therapeutics had revenue of 107.36M CAD in the quarter ending June 30, 2025, with 12.33% growth. This brings the company's revenue in the last twelve months to 384.56M, up 13.82% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
384.56M
Revenue Growth
+13.82%
P/S Ratio
1.47
Revenue / Employee
555.50K
Employees
745
Market Cap
609.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Curaleaf Holdings1.78B
dentalcorp Holdings1.66B
Trulieve Cannabis1.66B
Green Thumb Industries1.61B
Extendicare1.59B
WELL Health Technologies1.25B
Verano Holdings1.16B
Sienna Senior Living929.68M
Revenue Rankings

Knight Therapeutics News

More News